Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer
- PMID: 24166531
- DOI: 10.1200/JCO.2013.51.2954
Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer
Comment in
-
Reply to U.R. Mansmann et al and M.-W. An et al.J Clin Oncol. 2013 Dec 1;31(34):4374-5. doi: 10.1200/JCO.2013.52.5733. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166517 No abstract available.
Comment on
-
Evaluation of tumor-size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer.J Clin Oncol. 2013 Jun 10;31(17):2110-4. doi: 10.1200/JCO.2012.45.0973. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650411
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical